Guide for Families: Medications for Opioid Use Disorder
Contains detailed information about methadone, buprenorphine, and suboxone, including their advantages and risks.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Contains detailed information about methadone, buprenorphine, and suboxone, including their advantages and risks.
Provides guidance to State medical and osteopathic boards in assessing physician’s’ management of pain in their patients and whether opioid analgesics are being prescribed appropriately.
Lists factors that may help physicians determine whether to coprescribe naloxone to a patient or to a family member or close friend of the patient.
Describes risk factors for the development of opioid-related adverse events and how to mitigate these risks. Provides an overview of adverse events, including their symptoms and how to manage them.
The Council on Patient Safety in Women’s Health Care disseminates patient safety bundles to help facilitate the standardization process. This bundle reflects emerging clinical, scientific, and patient safety advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Although the components of a particular bundle may be adapted to local resources, standardization within an institution is strongly encouraged.